Power and sample size evaluation for the Cochran-Mantel-Haenszel mean score (Wilcoxon rank sum) test and the Cochran-Armitage test for trend-Reference-Cited by-同舟云学术

Power and sample size evaluation for the Cochran-Mantel-Haenszel mean score (Wilcoxon rank sum) test and the Cochran-Armitage test for trend

Published:2011-08-25 Issue:25 Volume:30 Page:3057-3066
ISSN:0277-6715
Container-title:Statistics in Medicine
language:en
Short-container-title:Statist. Med.

Author:

Lachin John M.¹

Affiliation:

1. The Biostatistics Center, Departments of Epidemiology and Biostatistics and Statistics; The George Washington University; 6110 Executive Boulevard, Suite 750; Rockville; MD; 20852; USA

Publisher

Wiley

Subject

Statistics and Probability,Epidemiology

Reference21 articles.

1. Individual comparisons by ranking methods;Wilcoxon;Biometrics Bulletin,1945

2. Some methods for strengthening common the χ2 tests;Cochran;Biometrics,1954

3. Chi-square tests with one degree of freedom: extensions of the Mantel-Haenszel procedure;Mantel;Journal of the American Statistical Association,1963

4. Statistical aspects of the analysis of data from retrospective studies of disease;Mantel;Journal of the National Cancer Institute,1959

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between bullying victimization and health risk behavior in adolescents;Revista Paulista de Pediatria;2025

2. Can patients with mild non-neoplastic lesions diagnosed at baseline screening be safely exempt from surveillance: evidence from multicenter community-based cohorts;Science China Life Sciences;2024-09-06

3. Knowledge and perceptions of uterine fibroids: A descriptive cross-sectional survey among women of childbearing age in KwaZulu-Natal, South Africa;2024-03-20

4. Trend in the Incidence of Severe Partial Edentulism among Adults Using the Korean National Health Insurance Service Claim Data, 2014–2018;Yonsei Medical Journal;2024

5. Identification and development of TP53 mutation-associated Long non-coding RNAs signature for optimized prognosis assessment and treatment selection in hepatocellular carcinoma;International Journal of Immunopathology and Pharmacology;2023-11-09